Serum Vitamin D Levels in Chronic Hepatitis B Patients Before and During Treatment

Author(s): Amal A. Mohamed, Sabry Abdo, Ebada Said, Waleed El Agawy, Peter Awad, Ayat I.M. Ghanem, Rania A. Khattab, Dalia A. El-damasy, Mahmoud Elkadeem, Sherief Abd-Elsalam*

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders

Volume 20 , Issue 6 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background & Aims: Hepatitis B is a potentially life-threatening liver infection and it is a major global health problem. Over the past decade, numerous studies have reported that patients with CLD, especially HCV-positive and HBV-positive patients, have decreased 25(OH) D levels. The current study was designed to assess the serum levels of vitamin D [25(OH) D3] in chronic hepatitis B patients, before and during treatment with antiviral therapy.

Methods: It was a prospective study in which 80 subjects were enrolled between December 2017 and June 2018. A total of 50 treatment-naïve chronic HBV patients and 30 healthy subjects were recruited. The studied cases received treatment in the form of Lamivudine 100 mg tablet, once daily. Full routine laboratory investigations, HBV DNA measurement by real-time PCR were conducted once before initiation of antiviral treatment and again at least 6 months later. Serum vitamin D level [25(OH)D3 was assessed twice, once before initiation of antiviral treatment and again at least 6 months later. This was done for all the patients enrolled in the study.

Results: The studied cases showed a significantly low mean serum Vitamin D level when assessed before treatment (21.6 ± 5.8 ng/ml), compared to the level after 6 ms of treatment (31.1 ± 7.3 ng/ml) which was comparable to that of the control group (33.4 ± 5 ng/ml).

Conclusion: The present study highlights the impact of antiviral therapy on vitamin D deficiency in CHB patients, where effective therapy improves vitamin D levels. Meanwhile, it is recommended to study the impact of vitamin D replacement and correction on the disease progression or regression.

Keywords: Chronic liver disease, hepatitis B, antiviral therapy, vitamin D levels, lamivudine, serum.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 6
Year: 2020
Published on: 20 January, 2021
Page: [840 - 847]
Pages: 8
DOI: 10.2174/1871526519666191112112903
Price: $65

Article Metrics

PDF: 13